Showing 1309 - 1320 of 1511
From the longterm consequences of the Snowden leaks on U.S.-China relations to the big picture on electric vehicles.
The former Director of National Intelligence talks about the failure of U.S. businesses to think about the big picture.
The new bidding system for generic drugs upends the business of global drug makers in China. The big winners have been Chinese drug makers.
Trump’s November executive order branded 31 companies as having ties to the People’s Liberation Army. Who are they, and who has stakes in them?
Despite growth, China’s economy still faces serious challenges, which can only be addressed with a more expansionary fiscal policy.
For more than a decade, the U.S. has been sounding the alarm about China’s stranglehold on rare earths. Now with new investments and new operations...
This week, we’re clarifying supply chains and mail logistics.
How did USPS end up subsidizing China’s e-commerce?
Making sense of the many challenges Biden faces.
The Japanese investment fund has bet heavily on startups in the U.S. and China.
Definitions matter, says the former Australian PM.
China makes most of the world’s solar panels. But its state policy banks seem reluctant to finance overseas solar projects. Why?